Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.

Brod M, Rana A, Barnett AH.

Curr Med Res Opin. 2012 Dec;28(12):1947-58. doi: 10.1185/03007995.2012.743457. Epub 2012 Nov 14.

PMID:
23150950
2.

Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses.

Brod M, Rana A, Barnett AH.

Curr Med Res Opin. 2012 Dec;28(12):1933-46. doi: 10.1185/03007995.2012.743458. Epub 2012 Nov 14.

PMID:
23150949
3.
5.
7.

Self-reported non-severe hypoglycaemic events in Europe.

Östenson CG, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Markert Jensen M, Pedersen-Bjergaard U.

Diabet Med. 2014 Jan;31(1):92-101. doi: 10.1111/dme.12261. Epub 2013 Jul 26.

8.

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.

Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP; DARTS/MEMO Collaboration..

Diabet Med. 2005 Jun;22(6):749-55.

PMID:
15910627
9.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
11.

Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey.

Akram K, Pedersen-Bjergaard U, Carstensen B, Borch-Johnsen K, Thorsteinsson B.

Diabet Med. 2006 Jul;23(7):750-6.

PMID:
16842479
12.

Self-Treated Hypoglycemia in Type 2 Diabetes Mellitus: Results from the Second Wave of an International Cross-Sectional Survey.

Brod M, Galstyan G, Unnikrishnan AG, Harman-Boehm I, Prusty V, Lavalle F, McGill M, Murphy A, Puchulu F.

Diabetes Ther. 2016 Jun;7(2):279-93. doi: 10.1007/s13300-016-0164-0. Epub 2016 Mar 21.

13.
15.
16.

Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.

Kulzer B, Seitz L, Kern W.

Exp Clin Endocrinol Diabetes. 2014 Mar;122(3):167-72. doi: 10.1055/s-0033-1363688. Epub 2014 Mar 18.

PMID:
24643694
17.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

18.
19.

[Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].

Ratzmann KP, Schimke E.

Med Klin (Munich). 1995 Oct 15;90(10):557-61. German.

PMID:
7500918
20.

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.

Kølendorf K, Ross GP, Pavlic-Renar I, Perriello G, Philotheou A, Jendle J, Gall MA, Heller SR.

Diabet Med. 2006 Jul;23(7):729-35.

PMID:
16842476

Supplemental Content

Support Center